retinal neurons to be generated, multipotent retinal pro-
genitor cells must proliferate and also be competent to ginning to be explored (Van Raay and Vetter, 2004). We therefore investigated the expression and function of initiate expression of proneural and neurogenic genes. Since multiple steps in eye development are well deXfz5, which is expressed in the eye starting at late neurula stages (Sumanas and Ekker, 2001). We found that fined at the molecular level, retinal development provides an ideal system for investigating whether specific Xfz5 expression began at stage 17 in the emerging optic vesicles ( Figure 1A mouth, and otic vesicles appeared unaffected. The Xfz5 UTR MO (10 ng) produced a similar but less penetrant In this study, we provide evidence that Xfz5 acts through canonical β-catenin signaling to regulate the phenotype (50% with reduced eye size; n = 54). In the following analyses, we saw similar phenotypes using proliferation and neural potential of retinal progenitors and that it does so by regulating the regional expresthese two independent morpholinos, so we show data only for the ATG MO, which will be referred to simply sion of the neural competence factor Sox2. Blocking either Xfz5 or canonical Wnt signaling did not affect the as Xfz5 MO. There were no effects with a standard control MO or a Xfz5 ATG MO containing five mismatches expression of multiple retinal progenitor markers but instead inhibited the expression of Sox2, resulting in re-(data not shown). The Xfz5 ATG MO could efficiently inhibit expression of GFP when it was coinjected with duced cell proliferation and a failure to properly initiate the expression of proneural genes required for neuro-GFP RNA in which the Xfz5 ATG MO target sequence replaced the eGFP ATG start codon (data not shown Figure S1A in the Supplemental Data available MO-injected sides with a 4 hr pulse of BrDU ( Figures  2B and 2C ). However, we observed a 70% decrease with this article online). Since we observed that every cell in the retina was in the number of cells positive for the mitotic marker phosphohistone 3 (HP3) within the eye domain on the proliferating, but that the number of mitotic cells was reduced by the Xfz5 MO, we reasoned that the cells Xfz5 MO-injected side ( Figure 2D ). Since there were on average 27% fewer cells on the Xfz5 MO-injected side may be proliferating more slowly. This would predict that expansion of the progenitor population within the (Figure 2A) , we adjusted the number of HP3+ cells on the control side by 27% (adjusted n = 7.2 HP3+ cells retina would be reduced when Xfz5 is inhibited. We performed retinal clone size analysis by injecting mRNA versus unadjusted n = 9.8 HP3+ cells) and found that the difference compared to the Xfz5 MO-injected side for GFP either alone (300 pg) or together with the Xfz5 MO (2.5 ng) at the 32-cell stage into blastomere V1.2.1, (n = 2.9 HP3+ cells) was still highly significant (p < 0.01, n = 17 embryos). There was no difference in HP3 stainwhich makes a small contribution to the retina (Huang The suppression of proneural and neurogenic gene expression by the Xfz5 MO was transient, resulting in a delay rather than a complete loss of gene expression within the developing eye (data not shown). We reasoned that the efficacy of the MO may decay or that the continued expression of Xfz5 (see Figure 2E ) may effectively titrate out the Xfz5 MO over time. To test this hypothesis, we injected increasing amounts of the Xfz5 MO and found that at higher doses we further delayed the recovery of proneural or neurogenic gene expression and also generated increasingly smaller eyes (Figure S2) . Consistent with the delay in gene expression caused by the Xfz5 MO, there was an apparent delay in retinal development at later stages. At stage 41, the Figure 2D ). We found that vesicles ( Figure 4A ) and by stage 24 was strongly exon average there were 23% fewer cells within the distal pressed in the developing eye ( Figure 4B ). In the mature optic vesicle on the Sox2 MO-injected side (n = 3; data retina (stage 41), Sox2 expression was restricted to the not shown), so we adjusted the number of HP3+ cells CMZ, but was excluded from the most peripheral reon the control side by 23% (adjusted n = 6.9 HP3+ cells gion ( Figure 4C ), much like Xfz5. Since Xfz5 is required versus unadjusted n = 9 HP3+ cells) and found that the for progenitors to express proneural and neurogenic difference compared to the Sox2 MO-injected side (n = genes, it may do so by regulating the expression of 3.2 HP3+ cells) was still highly significant (p < 0.01, n = Sox2. We observed a dramatic decrease in Sox2 ex-8). In addition, TUNEL analysis on whole-mount empression in the optic vesicle on the Xfz5 MO-injected bryos at optic vesicle stages showed that the Sox2 MO side (Figures 4D-4F ; 70%, n = 92). Sox2 expression in caused no increase in cell death within the eye (n = 15) other regions of the CNS was unaffected, suggesting compared to control embryos (n = 12; data not shown Figure 5D ). Although this is an indirect opment, then directly inhibiting Sox2 expression should measure, inhibition of Sox2 expression appears to have show similar effects. To test this, we injected 10 ng of effects on retinal cell proliferation similar to those observed with inhibition of Xfz5. a morpholino targeted against Sox2 into dorsal animal side, but did not affect intensity of expression of Rx or En, suggesting that retinal progenitors are specified and the nervous system is patterned normally ( Figure  5G ; 98%, n = 56). Similarly, intensity of expression of the retinal progenitor genes Pax6, Six6, Chx10, and Six3 appeared unaltered by the Sox2 MO, although the domain of expression was reduced ( Figures 5H-5J and Figure S1D ; n = 33/33 for Pax6, n = 23/23 for Six6, 22/ 23 for Chx10, and n = 36/37 for Six3). However, the Sox2 MO dramatically inhibited expression of Xash3 ( Figure  5K ; 82%, n = 55) and Xdelta-1 (Figure 5L ; 85%, n = 71). Thus, blocking Sox2 expression has strikingly similar effects on eye development and neural gene expression as blocking Xfz5 expression. In addition, Xfz5 is required for normal Sox2 expression, but not vice versa. These findings support the conclusion that Xfz5 regulates the expression of Sox2, which is required for retinal progenitors to be neural competent and initiate proneural and neurogenic gene expression.
To assess whether the effects on eye development due to the Xfz5 MO can be rescued by restoring Sox2 expression, we coinjected Sox2 mRNA (100 pg) together with 10 ng of the Xfz5 MO. We found a 50% reduction in the number of embryos with reduced eye size (35%, n = 88 versus 73% with the Xfz5 MO alone) and the effects on eye development were less severe compared to those observed with injection of the Xfz5 MO alone (data not shown). In addition, we found Sox2 mRNA could also rescue the reduction in HP3+ cells in the optic vesicle caused by the Xfz5 MO. We found only a 25% decrease in HP3+ cells on the Xfz5MO + Sox2 RNA-injected side (9.4 ± 0.7 cells control side, 7.1 ± 0.6 cells injected side; n = 26) compared to a 70% decrease with the Xfz5 MO alone ( Figure 2D ). Thus, Sox2 can partially rescue the eye size defects associated with inhibition of Xfz5, potentially by rescuing the effects on progenitor cell proliferation. The converse was not true; that is, 90% of Sox2 MO-injected embryos still had significantly reduced eye size on the injected side when coinjected with 500 pg of Xfz5 RNA (n = 62). TCF/Lef Signaling Is Active in the Developing proneural gene expression when Xfz5 is inhibited, they may remain in an undifferentiated state, they may delay and lens were apparent (Figures 6F and 6G ; 40% reduced or missing eye, n = 65). Control Rx:GFP embryos their differentiation, or they may adopt a nonneural fate that is not dependent upon proneural gene expression. showed slightly reduced eye size in only 12% of embryos at stage 41 (n = 59). To further assess whether To investigate the effects of Xfz5 on retinal progenitors, we generated a dominant-negative form of the Xfz5 reWnt/β-catenin/TCF signaling is required for normal eye development, we generated transgenic embryos exceptor (dnXfz5) consisting of just the soluble extracellular domain. To ensure that this dnXfz5 is behaving simipressing Axin under the control of the Rx promoter (Rx:Axin), since axin specifically antagonizes this pathlarly to the Xfz5 MO, we generated transgenic embryos expressing this construct and analyzed expression of way (Ikeda et al., 1998; Itoh et al., 1998; Sakanaka et al., 1998). Rx:Axin transgenic embryos showed signifiRx and Sox2. Since dnXfz5 was not epitope tagged, we were not able to presort the embryos that were excant eye defects at stage 41 (36% reduced or missing eye, n = 53), similar to what was observed in pressing the transgene, but our typical transgenic rates are around 30%-40%. All of the embryos exhibited norRx:⌬NTcf3-GFP transgenic embryos (data not shown).
To transcription was shown to be regulated by Wnt7a activity, and it was argued that this was directly through In these experiments, SoxB1 function was blocked in progenitors that were already expressing these genes, Wnt/β-catenin signaling, since TCF/Lef sites within the Ngn1 promoter were shown to be important for transuggesting that downregulation of SoxB1 expression or function is critical to allow neurogenesis to proceed. scriptional activity, and β-catenin could be detected in When Xfz5 or Sox2 was inhibited in the developing Xencomplex with the Ngn1 promoter in cultured cortical opus retina, we did not observe premature neurogenprogenitor cells (Hirabayashi et al., 2004) . In the retina, esis, but rather inhibition of neurogenesis. These findit remains to be determined which genes are directly ings are not inconsistent with those in chick spinal cord regulated by Xfz5 signaling. studies, since Sox2 was inhibited prior to its expression in the optic vesicle, thus preventing the acquisition of neural potential by progenitors in the retina. 
